• Should Everybody Be On A GLP-1?

  • 2024/11/03
  • 再生時間： 13 分
  • ポッドキャスト

Should Everybody Be On A GLP-1?

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • Semaglutide and tirzepatide have reshaped diabetes and weight-loss treatment, but could these drugs hold even greater potential? Join Dr. David S. Filippi—and his AI friends—on a quick journey into emerging data, revealing mechanisms, benefits, and mysteries of these breakthrough medications. Are they the most significant drugs of our time? Listen in and decide. Visit us at significant-podcast.com.

    Note: Signet is a brief, AI-generated summary of the Significant Podcast and may contain amusing or unexpected errors.
    続きを読む 一部表示

あらすじ・解説

Semaglutide and tirzepatide have reshaped diabetes and weight-loss treatment, but could these drugs hold even greater potential? Join Dr. David S. Filippi—and his AI friends—on a quick journey into emerging data, revealing mechanisms, benefits, and mysteries of these breakthrough medications. Are they the most significant drugs of our time? Listen in and decide. Visit us at significant-podcast.com.

Note: Signet is a brief, AI-generated summary of the Significant Podcast and may contain amusing or unexpected errors.
続きを読む 一部表示

Should Everybody Be On A GLP-1?に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。